Nanomedicines in renal transplant rejection--focus on sirolimus (Q36920414)

17 August 2017

9 references

1 July 2019

25 June 2019

6 August 2019

1 October 2019

11 November 2019

24 July 2020

23 November 2020

24 January 2021

30 June 2021

Nanomedicines in renal transplant rejection--focus on sirolimus (English)

1 reference

pharmaceutical preparation

17 August 2017

1 reference

6 August 2019

1 reference

1 October 2019

1 reference

11 November 2019

1 reference

24 July 2020

1 reference

23 November 2020

kidney transplantation

1 reference

24 January 2021

1 reference

30 June 2021

1 reference

Li-Jiuan Shen

1

1 reference

17 August 2017

Fe-Lin Lin Wu

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

International Journal of Nanomedicine

17 August 2017

11 references

17 August 2017

1 July 2019

25 June 2019

6 August 2019

1 October 2019

11 November 2019

1 June 2020

24 July 2020

23 November 2020

24 January 2021

30 June 2021

2

1 reference

17 August 2017

1

1 reference

17 August 2017

25-32

1 reference

17 August 2017

What is nanomedicine?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Drug targeting with nano-sized carrier systems

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

The rise and rise of drug delivery

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Immunosuppressive drugs for kidney transplantation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Transplantation--a medical miracle of the 20th century

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Nanosuspensions: a promising drug delivery strategy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Sirolimus: a ten-year perspective

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Tacrolimus: a further update of its use in the management of organ transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Pharmacokinetics of tacrolimus-based combination therapies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Nanosizing: a formulation approach for poorly-water-soluble compounds

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Initiation of angiogenic Kaposi's sarcoma lesions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Rapamycin: clinical results and future opportunities

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Clinical pharmacokinetics of sirolimus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Solubilization of rapamycin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Sirolimus: a new agent for prevention of renal allograft rejection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

In vivo immunosuppressive mechanisms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Pharmacokinetics of rapamycin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Immunobiology of renal transplantation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Effects of conversion from sirolimus oral solution to tablets in stable Taiwanese renal transplant recipients.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Liposomal formulations of tacrolimus and rapamycin increase graft survival and fiber outgrowth of dopaminergic grafts

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673820

Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin

4 September 2018

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent*

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Sirolimus-tacrolimus combination immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Successful homotransplantation of the human kidney between identical twins

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Transplantation 50 years later--progress, challenges, and promises

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Three generations of cyclosporine a formulations: an in vitro comparison

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNANO.2007.2.1.25

Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17722509

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17722509

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/NANO.2007.2.1.25

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

17722509

1 reference